erdman atcc 35801 strain (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
95
Structured Review
ATCC
erdman atcc 35801 strain
Erdman Atcc 35801 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 387 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mycobacterium+tuberculosis+atcc+35801/Mycobacterium+tuberculosis+(Zopf)+Lehmann+and+Neumann/bio_rxiv__2025__10__06__680645-47-1-2
Average 95 stars, based on 387 article reviews
Erdman Atcc 35801 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 387 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mycobacterium+tuberculosis+atcc+35801/Mycobacterium+tuberculosis+(Zopf)+Lehmann+and+Neumann/bio_rxiv__2025__10__06__680645-47-1-2
Average 95 stars, based on 387 article reviews
erdman atcc 35801 strain - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Transferring:Article Title: Design, synthesis and antimycobacterial activity of imidazo[1,5- a ]quinolines and their zinc-complexes Article Snippet: .. For Sterility:Article Title: Design, synthesis and antimycobacterial activity of imidazo[1,5- a ]quinolines and their zinc-complexes Article Snippet: .. For Positive Control:Article Title: Design, synthesis and antimycobacterial activity of imidazo[1,5- a ]quinolines and their zinc-complexes Article Snippet: .. 35 HepG2 Assay plates were prepared as described for Infection:Article Title: Discovery of antimycobacterial spiro-piperidin-4-ones: an atom economic, stereoselective synthesis, and biological intervention. Article Snippet: An atom economic and stereoselective synthesis of several spiro-piperidin-4-ones through 1,3-dipolar cycloaddition of azomethine ylides generated in situ from isatin and R-amino acids viz. proline, phenylglycine, and sarcosine to a series of 1-methyl-3,5-bis[(E)-arylmethylidene]tetrahydro-4(1H)-pyridinones is described.. These compounds were evaluated for their in vitro and in vivo activity against Mycobacterium tuberculosis H37Rv (MTB), multidrug resistant Mycobacterium tuberculosis (MDR-TB), and Mycobacterium smegmatis (MC).. Compound 4-(4-fluorophenyl)-5-phenylpyrrolo(spiro[2.3′′]oxindole)spiro[3.3′]-1′-methyl-5′-(4-fluorophenylmethylidene)piperidin-4′-one (4e) was found to be the most active in vitro with a MIC value of 0.07 μM against MTB and was 5.1 and 67.2 times more potent than isoniazid and ciprofloxacin, respectively. Article Title: Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives Article Snippet: 13 , Manna and Agrawal 2010 (ref. ) , The in vitro antitubercular activity was assessed by measuring the growth of Mtb (H37Rv) and a multidrug-resistant H37Rv strain using Lowenstein–Jensen (L.–J.) medium , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Mtb ATCC 35801. Test compounds (25 mg kg −1 ) were evaluated for their ability to reduce bacterial loads in lung and spleen tissues compared to standard drugs and a negative control. Viable bacterial counts were determined by serial 10-fold dilutions followed by inoculation onto 7H10 agar plates. The test compounds showed significant bacterial reductions, comparable to standard treatments , NA , Rifampicin and isoniazid. .. 14 , Manna and Agrawal 2011 (ref. ) , The in vitro antitubercular activity was screened against Mtb using egg-based Lowenstein–Jensen and Ogawa media. The growth of Mtb (H37Rv) was measured after 3 and 6 weeks, with cultures incubated at 37 °C in ambient air for up to 6 weeks , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Modification:Article Title: Antimycobacterial activity of novel N-(substituted)-2-isonicotinoylhydrazinocarbothioamide endowed with high activity towards isoniazid resistant tuberculosis. Article Snippet: Various isonicotinoylhydrazinocarbothioamides were prepared by reacting isonicotinoyl hydrazide (INH) with appropriate potassium salt of substituted phenyl thiocarbamate and were tested for their antimycobacterial activity in vitro against Mycobacterium tuberculosis H37Rv and INH resistant M. tuberculosis using the agar dilution method.. Among the synthesized compounds, 2-isonicotinoyl-N-[2-(trifluoromethyl)phenyl]hydrazinecarbothioamide (4i) was found to be the most potent compound with minimum inhibitory concentration of 0.58 mM against M. tuberculosis H37Rv and INH resistant M. tuberculosis.. When compared to INH, 4i was found to be 1.24 and 157 times more active against M. tuberculosis H37Rv and INH resistant M. tuberculosis respectively, with a selectivity index of >218. In Vitro:Article Title: Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives Article Snippet: 13 , Manna and Agrawal 2010 (ref. ) , The in vitro antitubercular activity was assessed by measuring the growth of Mtb (H37Rv) and a multidrug-resistant H37Rv strain using Lowenstein–Jensen (L.–J.) medium , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Mtb ATCC 35801. Test compounds (25 mg kg −1 ) were evaluated for their ability to reduce bacterial loads in lung and spleen tissues compared to standard drugs and a negative control. Viable bacterial counts were determined by serial 10-fold dilutions followed by inoculation onto 7H10 agar plates. The test compounds showed significant bacterial reductions, comparable to standard treatments , NA , Rifampicin and isoniazid. .. 14 , Manna and Agrawal 2011 (ref. ) , The in vitro antitubercular activity was screened against Mtb using egg-based Lowenstein–Jensen and Ogawa media. The growth of Mtb (H37Rv) was measured after 3 and 6 weeks, with cultures incubated at 37 °C in ambient air for up to 6 weeks , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Activity Assay:Article Title: Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives Article Snippet: 13 , Manna and Agrawal 2010 (ref. ) , The in vitro antitubercular activity was assessed by measuring the growth of Mtb (H37Rv) and a multidrug-resistant H37Rv strain using Lowenstein–Jensen (L.–J.) medium , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Mtb ATCC 35801. Test compounds (25 mg kg −1 ) were evaluated for their ability to reduce bacterial loads in lung and spleen tissues compared to standard drugs and a negative control. Viable bacterial counts were determined by serial 10-fold dilutions followed by inoculation onto 7H10 agar plates. The test compounds showed significant bacterial reductions, comparable to standard treatments , NA , Rifampicin and isoniazid. .. 14 , Manna and Agrawal 2011 (ref. ) , The in vitro antitubercular activity was screened against Mtb using egg-based Lowenstein–Jensen and Ogawa media. The growth of Mtb (H37Rv) was measured after 3 and 6 weeks, with cultures incubated at 37 °C in ambient air for up to 6 weeks , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Incubation:Article Title: Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives Article Snippet: 13 , Manna and Agrawal 2010 (ref. ) , The in vitro antitubercular activity was assessed by measuring the growth of Mtb (H37Rv) and a multidrug-resistant H37Rv strain using Lowenstein–Jensen (L.–J.) medium , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Mtb ATCC 35801. Test compounds (25 mg kg −1 ) were evaluated for their ability to reduce bacterial loads in lung and spleen tissues compared to standard drugs and a negative control. Viable bacterial counts were determined by serial 10-fold dilutions followed by inoculation onto 7H10 agar plates. The test compounds showed significant bacterial reductions, comparable to standard treatments , NA , Rifampicin and isoniazid. .. 14 , Manna and Agrawal 2011 (ref. ) , The in vitro antitubercular activity was screened against Mtb using egg-based Lowenstein–Jensen and Ogawa media. The growth of Mtb (H37Rv) was measured after 3 and 6 weeks, with cultures incubated at 37 °C in ambient air for up to 6 weeks , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Negative Control:Article Title: Advancements in the design and development of pyrazoline-based antimycobacterial agents: an update and future perspectives Article Snippet: 13 , Manna and Agrawal 2010 (ref. ) , The in vitro antitubercular activity was assessed by measuring the growth of Mtb (H37Rv) and a multidrug-resistant H37Rv strain using Lowenstein–Jensen (L.–J.) medium , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with Mtb ATCC 35801. Test compounds (25 mg kg −1 ) were evaluated for their ability to reduce bacterial loads in lung and spleen tissues compared to standard drugs and a negative control. Viable bacterial counts were determined by serial 10-fold dilutions followed by inoculation onto 7H10 agar plates. The test compounds showed significant bacterial reductions, comparable to standard treatments , NA , Rifampicin and isoniazid. .. 14 , Manna and Agrawal 2011 (ref. ) , The in vitro antitubercular activity was screened against Mtb using egg-based Lowenstein–Jensen and Ogawa media. The growth of Mtb (H37Rv) was measured after 3 and 6 weeks, with cultures incubated at 37 °C in ambient air for up to 6 weeks , The antitubercular activity of test compounds was studied in six-week-old female CD-1 mice infected with |